PRESS-RELEASE ·Filed May 27, 2026
Press release · Announcement
Actionable Insight • Neutral
No trading implications from this filing. Monitor for future press releases regarding pipeline updates, clinical trial results, or financial performance.
Final — all horizons settled through T+60d
AGMB ▲ +15.08% at T+60d
NEUTRAL call +15.08% · α vs SPY +13.20% · entry $11.67 → $13.43
T+1d
-1.11%
call -1.11% · α -1.67%
$11.54
settled 5mo ago
T+5d
+2.83%
call +2.83% · α +2.36%
$12.00
settled 5mo ago
T+20d
+15.08%
call +15.08% · α +16.98%
$13.43
settled 4mo ago
T+60d
+15.08%
call +15.08% · α +13.20%
$13.43
settled 2mo ago
Price Chart
Loading chart...
Executive Summary
Agomab Therapeutics held its Annual General Meeting on May 26, 2026. The press release announces the meeting results but provides no financial data, guidance, or material business developments. This is a routine corporate governance event with no actionable trading information.
Key Facts
- Annual General Meeting held on May 26, 2026
- No financial results, guidance, or material business updates disclosed
- Routine governance event with no stock-moving content
Financial Impact
No financial impact disclosed
Risk Factors
- No material risks disclosed in this filing
Market Snapshot
Exchange
Nasdaq
Sector
Biological Products, (No Diagnostic Substances)
Analyst Consensus
90% bullish (10 analysts)
Investment Themes
Documents Analyzed
This report is based on 1 press release from GlobeNewswire.
| Document | Accession Number |
|---|---|
| PRESS-RELEASE Data (Synthetic) | press-3301675 |
14 reports for AGMB
71% Hit rate @ T+5 Went positive at some point 5 of 8 best @ T+5▲ +6.98%
Filters
Rows
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 22, 2026 4d ago | Insider Buy | $9.26 | awaiting T+5 | — | $8.57 (−7.45%) |
Oct 13, 2026 13d ago | 6-K | $8.69 $9.11 | ▲ +4.83% | ▲ +4.38% | $8.57 (−1.38%) |
Oct 13, 2026 13d ago | Press Release | $8.69 $9.11 | ▲ +4.83% | ▲ +4.38% | $8.57 (−1.38%) |
Oct 1, 2026 25d ago | 6-K | $8.65 $9.22 | ▲ +6.59% | ▲ +5.29% | $8.57 (−0.92%) |
Oct 1, 2026 25d ago | Press Release | $8.65 $9.22 | ▲ +6.59% | ▲ +5.29% | $8.57 (−0.92%) |
Sep 14, 2026 6w ago | 6-K | $12.16 $11.49 | ▼ −5.51% | ▼ −7.64% | $8.57 (−29.52%) |
Sep 14, 2026 6w ago | Press Release | $12.16 $11.49 | ▼ −5.51% | ▼ −7.64% | $8.57 (−29.52%) |
Sep 11, 2026 6w ago | 6-K | $12.28 $11.70 | ▼ −4.72% | ▼ −4.83% | $8.57 (−30.21%) |
Aug 10, 2026 11w ago | 6-K | $14.85 $13.73 | ▼ −7.54% | ▼ −7.14% | $8.57 (−42.29%) |
Jun 23, 2026 17w ago | 6-K | $12.68 $11.87 | ▼ −6.39% | ▼ −8.10% | $8.57 (−32.41%) |
Showing 10 of 14
US Market Status
Market Closed — Opens Tue (15h 55m)
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers